Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 12/20 | 0.55 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | FPR2 | P25090 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953210 | 0.89 | AAK1 (0.46) | AAK1MAPK1MMP1 | |
| SCHEMBL30953402 | 0.87 | AAK1 (0.60) | AAK1GSK3BCDK5DYRK1ACDK5R1 | |
| SCHEMBL30953311 | 0.87 | AAK1 (0.44) | AAK1GSK3BMAPK1MMP1MAPT | |
| SCHEMBL30953439 | 0.87 | AAK1 (0.44) | AAK1CDK5DYRK1ACDK5R1MAPK1 | |
| SCHEMBL30953388 | 0.86 | AAK1 (0.46) | AAK1GSK3BMAPK1MMP1MAPT | |
| SCHEMBL30953223 | 0.86 | AAK1 (0.44) | AAK1GSK3BMAPK1MAPT | |
| SCHEMBL30953417 | 0.86 | AAK1 (0.44) | AAK1GSK3BMAPT | |
| SCHEMBL30953416 | 0.84 | AAK1 (0.42) | AAK1GSK3BMAPK1MAPT | |
| SCHEMBL30953508 | 0.84 | AAK1 (0.42) | AAK1GSK3BMAPK1MAPT | |
| SCHEMBL30953227 | 0.83 | AAK1 (0.41) | AAK1MAPK1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |